Lee Ainslie's ABBV Position Overview
Lee Ainslie (via Maverick Capital LTD) currently holds 1,018 shares of AbbVie Inc. (ABBV) worth $266,299, representing 0.00% of the portfolio. First purchased in 2014-Q2, this long-term strategic position has been held for 22 quarters.
Based on 13F filings, Lee Ainslie has maintained a strategic position in ABBV, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2014, adding 1.49 M shares. Largest reduction occurred in Q4 2014, reducing 4.72 M shares.
Analysis based on 13F filings available since 2013 Q2
Lee Ainslie's AbbVie (ABBV) Holding Value Over Time
Track share changes against reported price movement
Quarterly AbbVie (ABBV) Trades by Lee Ainslie
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2026 | +1,018 | New Buy | 1,018 | $261.59 |
| Q4 2023 | -6,073 | Sold Out | 0 | $0.00 |
| Q3 2023 | +6,073 | New Buy | 6,073 | $149.06 |
| Q4 2021 | -11,681 | Sold Out | 0 | $0.00 |
| Q3 2021 | -2,598 | Reduce 18.19% | 11,681 | $107.87 |
| Q2 2021 | +14,279 | New Buy | 14,279 | $112.61 |
| Q1 2021 | -6,210 | Sold Out | 0 | $0.00 |
| Q4 2020 | +4,188 | Add 207.12% | 6,210 | $107.09 |
| Q3 2020 | +2,022 | New Buy | 2,022 | $87.54 |
| Q3 2017 | -57,400 | Sold Out | 0 | $0.00 |
| Q2 2017 | +13,000 | Add 29.28% | 57,400 | $72.51 |
| Q1 2017 | -6,520 | Reduce 12.80% | 44,400 | $65.16 |
| Q4 2016 | +1,320 | Add 2.66% | 50,920 | $62.63 |
| Q3 2016 | -940 | Reduce 1.86% | 49,600 | $63.06 |
| Q2 2016 | +7,370 | Add 17.07% | 50,540 | $61.91 |
| Q1 2016 | +43,170 | New Buy | 43,170 | $57.12 |
| Q3 2015 | -3,950 | Sold Out | 0 | $0.00 |
| Q2 2015 | -370 | Reduce 8.56% | 3,950 | $67.09 |
| Q1 2015 | +4,320 | New Buy | 4,320 | $58.56 |
| Q4 2014 | -4.72 M | Sold Out | 0 | $0.00 |
| Q3 2014 | +1.49 M | Add 46.01% | 4.72 M | $57.76 |
| Q2 2014 | +3.24 M | New Buy | 3.24 M | $56.44 |
Lee Ainslie's AbbVie Investment FAQs
Lee Ainslie first purchased AbbVie Inc. (ABBV) in Q2 2014, acquiring 3,235,133 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Lee Ainslie has held AbbVie Inc. (ABBV) for 22 quarters since Q2 2014.
Lee Ainslie's largest addition to AbbVie Inc. (ABBV) was in Q2 2014, adding 3,235,133 shares worth $182.59 M.
According to the latest 13F filing for Q3 2026, Lee Ainslie's firm, Maverick Capital LTD, owns 1,018 shares of AbbVie Inc. (ABBV), valued at approximately $266,299.
As of the Q3 2026 filing, AbbVie Inc. (ABBV) represents approximately 0.00% of Lee Ainslie's publicly disclosed stock portfolio, making it one of their key holdings.
Lee Ainslie's peak holding in AbbVie Inc. (ABBV) was 4,723,578 shares, as reported at the end of Q3 2014.